Literature DB >> 11897415

The influence of core materials and film coating on the drug release from coated pellets.

J J Sousa1, A Sousa, M J Moura, F Podczeck, J M Newton.   

Abstract

The objective of this study was to analyse the influence of the composition of the core of the pellets on the in vitro drug release profile. The different materials (drugs and fillers) were chosen according to their relative solubility. Pellets were prepared by a standardised process of extrusion/spheronisation. A selected fraction size (1-1.4 mm diameter) of pellets of each preparation was coated with Surelease (an aqueous dispersion of ethyl cellulose) to give 5% weight gain. The dissolution studies were performed and data analysed in terms of the Area under the Curve (AUC) of the % dissolved as function of time and Mean Dissolution Time (MDT). ANOVA was applied in order to identify the influence factors and the relationship of cross effects. Canonical analysis and multiple regression were employed to quantify these relationships. The film coat was found to be the major factor controlling the drug release. The results however, show that both drug and filler solubility influenced the drug release profile. Some of the unusual results could only be explained if consideration was given to the physical characteristics of both powder and pellets. In particular, the specific surface area of calcium phosphate compared with other fillers played an important role on the release profile of the model drug.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897415     DOI: 10.1016/s0378-5173(01)00921-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores.

Authors:  Nikolett Kállai; Oliver Luhn; Judit Dredán; Kristóf Kovács; Miléna Lengyel; István Antal
Journal:  AAPS PharmSciTech       Date:  2010-03-17       Impact factor: 3.246

2.  Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms.

Authors:  Marija Tubic-Grozdanis; John M Hilfinger; Gordon L Amidon; Jae Seung Kim; Paul Kijek; Petra Staubach; Peter Langguth
Journal:  Pharm Res       Date:  2008-01-24       Impact factor: 4.200

3.  Microencapsulation Approach for Orally Extended Delivery of Glipizide: In vitro and in vivo Evaluation.

Authors:  A Abdelbary; N A El-Gendy; A Hosny
Journal:  Indian J Pharm Sci       Date:  2012-07       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.